Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (9): 893-897    DOI: 10.19485/j.cnki.issn2096-5087.2022.09.006
  论著 本期目录 | 过刊浏览 | 高级检索 |
丹参酮ⅡA抑制肺癌细胞增殖研究
王江峰1, 杨诗雨2, 李健强1, 陈晟1
1.中国科学院大学附属肿瘤医院胸外科,浙江 杭州 310022;
2.杭州医学院,浙江 杭州 310059
Inhibition of tanshinone ⅡA on lung cancer cell proliferation
WANG Jiangfeng1, YANG Shiyu2, LI Jianqiang1, CHEN Sheng1
1. Department of Thoracic Surgery, Cancer Hospital Affiliated to University of Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China;
2. Hangzhou Medical College, Hangzhou, Zhejiang 310059, China
全文: PDF(1176 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨丹参酮ⅡA(TanⅡA)抑制肺癌细胞增殖作用。方法 体外培养人肺癌细胞株A549、SK-MES-1、H446和H460,采用不同浓度的TanⅡA处理,对照组不做任何处理;采用CCK-8法测定细胞增殖,流式细胞术测定细胞凋亡,蛋白质印迹法测定细胞凋亡相关蛋白表达水平;比较不同浓度TanⅡA处理组和对照组的细胞凋亡率。结果 TanⅡA抑制肺癌细胞增殖具有时间依赖性和浓度依赖性,TanⅡA浓度越高(t=4.503、2.114、2.103、3.567,均P<0.05)、处理时间越长(t=5.189、3.079、3.023、3.845,均P<0.05),4种肺癌细胞存活率越低。TanⅡA处理48 h后,A549、SK-MES-1、H446和H460细胞IC50分别为(1.18±0.12)、(0.78±0.08)、(1.55±0.16)和(1.27±0.14)mg/mL。采用2.5 mg/mL TanⅡA处理48 h后,细胞凋亡率分别为(34.97±3.78)%、(37.62±2.48)%、(18.27±2.98)%和(19.17±2.30)%,与对照组 [(4.86±0.36)% 、(3.21±0.48)% 、(3.25±0.26)%和(2.66±0.19)%]相比显著增加(P<0.05);Akt1蛋白表达水平降低,Bax/Bcl-2蛋白表达比率升高,caspase-9和caspase-3蛋白表达水平升高。结论 TanⅡA可能通过影响细胞凋亡Bax/Bcl-2/caspase-9/caspase-3途径抑制肺癌细胞增殖,呈时间依赖性和浓度依赖性。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王江峰
杨诗雨
李健强
陈晟
关键词 丹参酮ⅡA肺癌细胞增殖细胞凋亡    
AbstractObjective To investigate the inhibition of tanshinoneⅡA (TanⅡA) on the proliferation of lung cancer cells. Methods Human lung cancer cell lines A549, SK-MES-1, H446 and H460 were cultured in vitro and treated with TanⅡA at concentrations of 0.3, 0.6, 1.3, 2.5, 5.0, 10.0 mg/mL, while untreated cells served as controls. Cell proliferation was measured by using CCK-8 assay, and apoptosis was measured using flow cytometry, while the expression of apoptosis-related proteins was determined using Western blotting. The apoptotic rate of lung cancer cells was compared between Tan ⅡA-treated cells and untreated cells. Results Tan ⅡA inhibited lung cancer cell proliferation in a time-dependent and concentration-dependent manner, and the survival rates of A549, SK-MS-1, H446 and H460 cells reduced with the concentration of TanⅡA (t=4.503, 2.114, 2.103 and 3.567; all P<0.05) and the duration of TanⅡA treatment (t=5.189, 3.079, 3.023 and 3.845; all P<0.05). The 48 h half maximal inhibitory concentrations (IC50 values) of TanⅡA were (1.18±0.12), (0.78±0.08), (1.55±0.16) and (1.27±0.14) mg/mL against A549, SK-MES-1, H446 and H460 cells, respectively. Following 48 h treatment with Tan ⅡA at a concentration of 2.5 mg/mL, the apoptotic rates of A549, SK-MS-1, H446 and H460 cells were (34.97±3.78)%, (37.62±2.48)%, (18.27±2.98)% and (19.17±2.30)%, which were significantly significantly higher than those of untreated cells [(4.86±0.36) %, (3.21±0.48) %, (3.25±0.26)% and (2.66±0.19)%, all P<0.05]. Reduced Akt1 protein expression, elevated Bax/Bcl-2 expression ratio, and elevated caspase-9 and caspase-3 protein expression were detected in lung cancer cells treated with 2.5 mg/mL TanⅡA for 48 h relative to untreated cells. Conclusion TanⅡA may inhibit lung cancer cell proliferation in a time- and concentration-dependent manner via the Bax/Bcl-2/caspase-9/caspase-3 pathway.
Key wordstanshinone ⅡA    lung cancer    cell proliferation    cell apoptosis
收稿日期: 2022-04-30      修回日期: 2022-07-21     
中图分类号:  R730.231  
基金资助:浙江省中医药科学研究基金项目(2021ZB032)
通信作者: 陈晟,E-mail:chensheng1117@163.com   
作者简介: 王江峰,硕士,主治医师,主要从事胸部肿瘤外科工作
引用本文:   
王江峰, 杨诗雨, 李健强, 陈晟. 丹参酮ⅡA抑制肺癌细胞增殖研究[J]. 预防医学, 2022, 34(9): 893-897.
WANG Jiangfeng, YANG Shiyu, LI Jianqiang, CHEN Sheng. Inhibition of tanshinone ⅡA on lung cancer cell proliferation. Preventive Medicine, 2022, 34(9): 893-897.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.09.006      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I9/893
[1] 裘凤黔,杜娟,纪云芳,等.2012—2016年黄浦区恶性肿瘤发病和死亡分析[J].预防医学,2021,33(7):697-700.
QIU F Q,DU J,JI Y F,et al.Morbidity and mortality of cancer in Huangpu District from 2012 to 2016[J].Prev Med,2021,33(7):697-700.
[2] TORRE L A,BRAY F,SIEGEL R L,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
[3] 方益荣,马岩,许树红,等.肺癌危险因素的病例对照研究[J].预防医学,2019,31(7):649-652.
FANG Y R,MA Y,XU S H,et al.A case control study of risk factors for lung cancer[J].Prev Med,2019,31(7):649-652.
[4] HOY H,LYNCH T,BECK M.Surgical treatment of lung cancer[J].Crit Care Nurs Clin North Am,2019,31(3):303-313.
[5] EL-HUSSEIN A,MANOTO S L,OMBINDA-LEMBOUMBA S,et al.A review of chemotherapy and photodynamic therapy for lung cancer treatment[J].Anticancer Agents Med Chem,2020,20(2):149-161.
[6] VINOD S K,HAU E.Radiotherapy treatment for lung cancer:current status and future directions[J].Respirology,2020,25(2):61-71.
[7] 杨渊,陈楠,马千里,等.阿帕替尼联合大剂量丹参酮ⅡA对肺腺癌A549细胞株凋亡及Bim异构体影响[J].现代肿瘤医学,2019,27(8):1319-1323.
YANG Y,CHEN N,MA Q L,et al.Effect of combination of apatinib and high-dose tanshinone ⅡA on apoptosis and Bim isomers of lung adenocarcinoma A549 cell line[J].J Mod Oncol,2019,27(8):1319-1323.
[8] 李娜. 丹参酮ⅡA对人肺癌细胞H2009凋亡的影响[J].四川医学,2022,43(3):222-226.
LI N.Effect of tanshinone ⅡA on apoptosis of human lung cancer cells H2009[J].Sichuan Med J,2022,43(3):222-226.
[9] 王介营,李芹,徐蒙,等.EGF及其受体在丹参酮ⅡA抑制甲状腺癌细胞增殖中的作用及其机制[J].国际医药卫生导报,2020,26(5):669-673.
WANG J Y,LI Q,XU M,et al.Effect and mechanisms of tanshinone ⅡA on the expression of EGF and EGFR in thyroid cancer cells[J].Int Med Health Guid News,2020,26(5):669-673.
[10] ZHANG X,ZHOU Y,GU Y E.Tanshinone ⅡA induces apoptosis of ovarian cancer cells in vitro and in vivo through attenuation of PI3K/AKT/JNK signaling pathways[J].Oncol Lett,2018,17(2):1896-1902.
[11] WON S H,LEE H J,JEONG S J,et al.Tanshinone ⅡA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway[J].Biol Pharm Bull,2010,33(11):1828-1834.
[12] LI Y,WANG Y,YU X,et al.Radix Tetrastigma inhibits the non-small cell lung cancer via Bax/Bcl-2/Caspase-9/Caspase-3 pathway[J].Nutr Cancer,2021,74(1):320-332.
[13] SU C C,LIN Y H.Tanshinone ⅡA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios[J].Int J Mol Med,2008,22(3):357-361.
[14] SU C.Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells[J].Int J Mol Med,2008,22(5):613-618.
[15] ASHOKKUMAR T,PRABHU D,GEETHA R,et al.Apoptosis in liver cancer(HepG2)cells induced by functionalized gold nanoparticles[J].Colloids Surf B Biointerfaces,2014,123:549-556.
[16] BRENTNALL M,RODRIGUEZ-MENOCAL L,DE GUEVARA R L,et al.Caspase-9,caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis[J/OL].BMC Cell Biol,2013,14[2022-07-21].http://www.biomedcentral.com/1471-2121/14/32.
[17] LI L Y,LUO X,WANG X.Endonuclease G is an apoptotic DNase when released from mitochondria[J].Nature,2001,412(6842):95-99.
[18] ZHANG C C,LI C G,WANG Y F,et al.Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation[J].Apoptosis,2019,24(3/4):312-325.
[19] WANG W T,ZHU M Y,XU Z X,et al.Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity[J/OL].Biol Res,2019,52(1)[2022-07-21].https://doi.org/10.1186/s40659-019-0242-7.
[20] 徐兴军,李珊珊,刘畅,等.川楝素诱导人胃癌MGC-803细胞凋亡及其机制[J].中国应用生理学杂志,2021,37(3):262-265.
XU X J,LI S S,LIU C,et al.Toosendanin induces apoptosis of human gastric cancer MGC-803 cells and its mechanism[J].Chin J Appl Physiol,2021,37(3):262-265.
[1] 项彩英, 汪德兵. 2011—2022年开化县肺癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(10): 885-889.
[2] 胡碧波, 傅克本, 顾永权. 2011—2018年余姚市恶性肿瘤发病趋势[J]. 预防医学, 2023, 35(1): 44-47,52.
[3] 赵紫暄, 王乐, 王悠清, 杨易, 董恒进, 杜灵彬. DRGs实施前后温岭市肺癌患者就诊费用及个人负担比较[J]. 预防医学, 2022, 34(7): 672-675.
[4] 李金, 黄文, 陈奇峰. 2014—2019年绍兴市肺癌发病趋势分析[J]. 预防医学, 2021, 33(9): 889-892.
[5] 陈静英, 朱匡纪. 2009-2018年婺城区肺癌死亡率变化趋势[J]. 预防医学, 2021, 33(2): 153-156.
[6] 林秀琴, 徐健, 许树红, 马岩, 方益荣. ADH、ALDH基因多态性与饮酒的交互作用对肺癌的影响研究[J]. 预防医学, 2021, 33(10): 1022-1025,1029.
[7] 方益荣, 马岩, 许树红, 裴迎新. 肺癌危险因素的病例对照研究[J]. 预防医学, 2019, 31(7): 649-652.
[8] 冯惠春, 郑香琴, 王黎红, 周秋萍. 肺癌患者“放疗助手”APP健康教育效果评价[J]. 预防医学, 2019, 31(2): 140-143.
[9] 孙一晟, 姚苹苹, 杨章女, 徐芳, 卢杭景, 伍立志, 朱函坪. CV-A16对长爪沙鼠肌肉细胞的杀伤机理研究[J]. 预防医学, 2018, 30(4): 325-328,333.
[10] 徐艳平, 刘文学. 龙游县肺癌死亡及减寿趋势分析[J]. 预防医学, 2018, 30(3): 266-269.
[11] 余智, 于民, 顾苏兵, 邵晓莉, 洪小琴, 张腾. [Gly14]-Humanin对局灶性脑缺血再灌注损伤大鼠氧化应激及神经细胞凋亡的影响[J]. 预防医学, 2018, 30(1): 55-58,62.
[12] 周彬, 孙一晟, 姚苹苹, 徐芳, 杨章女, 卢杭景, 朱函坪, 钱捷. 肠道病毒71型诱导沙鼠肌肉细胞凋亡及其机理研究[J]. 预防医学, 2017, 29(2): 109-112,116.
[13] 周慧芳,杨立伟,何徐军,余如平,徐敏,袁勉. 聚维酮碘稀释液对宫颈癌HeLa细胞生长的影响[J]. 预防医学, 2017, 29(1): 32-35.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed